SEC Form 4 · accession 0001144204-16-139122
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip P. Chan
Officer — President and CEO · Director
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 1:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 9, 2016 | P | 4,600 | $5.40 | A | 448,103 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Open market purchase.
- F2Includes (i) 126,248 shares of common stock, (ii) 313,855 shares of common stock issuable pursuant to stock options currently exercisable or exercisable within 60 days of the transaction date, and (iii) 8,000 shares of common stock issuable pursuant to warrants currently exercisable or exercisable within 60 days of the transaction date.